Meanwhile, a man and his wife have filed a lawsuit against Novo Nordisk, the maker of Wegovy and other semaglutide products
Funding ER reported being a shareholder of Maximon and its holding ventures, receiving grants from the Goldschmidt Jacobson Foundation, the Swiss National Foundation, Mildred Scheel Grant of the German Cancer Society and the Filling the Gap grant of the University of Zurich, Switzerland
The chewable tablet format is particularly beneficial for those who dislike mixing powders or have difficulty swallowing capsules
Clinics should date their regulatory statements and link to the actual FDA action
Bottesi G, Stefanelli A, Ambroso G, Baratto G, Carraro E, Cristaudo A, Giuntoli L, Maramaldi G, Meneghin M, Pozzati G, Semenzato A, Togni S, Vidotto G